Search - tctmd.com

Displaying 621 - 640 of 2435

Sort: Relevancy | Date

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Donald Cutlip

September 21, 2018

Presentation TCT 2018

The Methods for Coronary Stent Development

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Chuck Simonton

September 21, 2018

Presentation TCT 2018

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Presenter: Runlin Gao, Martin B. Leon, Shao-Liang Chen

September 21, 2018

Presentation TCT 2018

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Presenter: Runlin Gao, Martin B. Leon, Kefei Dou

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

September 21, 2018

Presentation TCT 2018

Drug-Eluting Stent Platforms and Outcomes 2018

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Gennaro Sardella

September 21, 2018

Presentation TCT 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

Presenter: George L Adams, Tony Das, Klaus Brechtel

September 21, 2018

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Presenter: Bernardo Cortese

September 21, 2018

Presentation TCT 2018

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Presenter: Azman Wan Ahmad

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

Presentation ESC 2018

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

Presenter: Raban V. Jeger

August 31, 2018

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

Presentation

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

August 17, 2018

Presentation CHIP Seattle 2018

Wire Across Perforation- Intact Pericardium

Presenter: Ashish Pershad

August 10, 2018

Presentation

Newer-Generation Ultrathin-Strut DES vs Older Second-Generation Thicker-Strut DES for CAD

July 11, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

Advertisement

The Methods for Coronary Stent Development

The Methods for Coronary Stent Development

Pulmonary Artery Denervation: Updates of Experimental and Clinical Studies

Iron-Based BRS: Design Features, Experimental Studies, and FIM Experience

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Drug-Eluting Stent Platforms and Outcomes 2018

First Report of the 12-Month Outcomes of SELUTION Trial: A Novel Sirolimus Coated DCB Technology Evaluated in SFA (MedAlliance)

What is the Future of Bioresorbable Scaffolds?

Clinical Performance of a Novel Sirolimus-Coated Balloon - Preliminary Data from the Worldwide EASTBOURNE Registry (Envision Scientific)

Treatment of Coronary Drug Eluting Stent Restenosis by a Sirolimus or a Paclitaxel Coated Balloon (B. Braun)

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

Wire Across Perforation- Intact Pericardium

Newer-Generation Ultrathin-Strut DES vs Older Second-Generation Thicker-Strut DES for CAD

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content